Skip to main content
. 2018 Mar 29;13(3):e0194458. doi: 10.1371/journal.pone.0194458

Table 1. Description of the collagen degradation and formation assays used in this study.

Biomarker Specification Process Surrogate measure
C1M[14] Neo-epitope of MMP-2,9,13 mediated degradation of type I collagen Type I collagen degradation Chronic inflammation
PINP[13] Internal epitope in the N-terminal pro-peptide of type I collagen Type I collagen formation Primarily bone synthesis
C3M[16] Neo-epitope of MMP-9 mediated degradation of type III collagen Type III collagen degradation Chronic inflammation
Pro-C3[15] Released N-terminal pro-peptide of type III collagen Type III collagen formation Fibrosis
C4M[18] Neo-epitope of MMP-2,9,12 mediated degradation of type IV collagen alpha 1 Type IV collagen degradation Chronic inflammation
P4NP7S[17] Internal epitope in the 7S domain of type IV collagen Type IV collagen formation Fibrosis